Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.26
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Journey Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | -11.43 | -14.67 | -3.85 | -29.63 | -43.99 | Upgrade
|
| Depreciation & Amortization | 4.35 | 3.52 | 3.77 | 4.37 | 2.56 | Upgrade
|
| Other Amortization | 0.47 | 0.31 | 0.36 | 0.06 | 2.57 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 3.14 | - | 13.82 | Upgrade
|
| Stock-Based Compensation | 6.29 | 6.1 | 2.61 | 4.43 | 2.47 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.21 | 0.52 | 0.44 | 0.28 | 0.05 | Upgrade
|
| Other Operating Activities | - | -1.13 | 0.44 | 0.77 | 5.64 | Upgrade
|
| Change in Accounts Receivable | -19.34 | 4.48 | 12.55 | -5.38 | 0.77 | Upgrade
|
| Change in Inventory | 4.81 | -4.23 | 3.95 | 1.74 | -8.46 | Upgrade
|
| Change in Accounts Payable | -7.2 | -2.1 | -18.42 | 14.34 | 20.39 | Upgrade
|
| Change in Income Taxes | 0.01 | 0.01 | 0.02 | 0.03 | -0.09 | Upgrade
|
| Change in Other Net Operating Assets | 9.82 | -1.92 | 0.24 | -4.55 | 2.1 | Upgrade
|
| Operating Cash Flow | -12.44 | -9.13 | 5.24 | -13.53 | -2.18 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -15 | -5 | -20 | -10 | Upgrade
|
| Investing Cash Flow | - | -15 | -5 | -20 | -10 | Upgrade
|
| Short-Term Debt Issued | - | - | 28 | 5 | 7 | Upgrade
|
| Long-Term Debt Issued | - | 10 | 15 | 19.76 | 9.54 | Upgrade
|
| Total Debt Issued | - | 10 | 43 | 24.76 | 16.54 | Upgrade
|
| Short-Term Debt Repaid | - | - | -30.95 | -2.86 | -6.19 | Upgrade
|
| Long-Term Debt Repaid | -0.63 | -1.25 | -21 | -5 | -5.3 | Upgrade
|
| Total Debt Repaid | -0.63 | -1.25 | -51.95 | -7.86 | -11.49 | Upgrade
|
| Net Debt Issued (Repaid) | -0.63 | 8.75 | -8.95 | 16.9 | 5.05 | Upgrade
|
| Issuance of Common Stock | 16.93 | 8.29 | 4.62 | 0.14 | 32.54 | Upgrade
|
| Other Financing Activities | -0.08 | -0.05 | -0.47 | -0.59 | -3.55 | Upgrade
|
| Financing Cash Flow | 16.23 | 16.99 | -4.8 | 16.46 | 53.02 | Upgrade
|
| Net Cash Flow | 3.79 | -7.13 | -4.56 | -17.08 | 40.84 | Upgrade
|
| Free Cash Flow | -12.44 | -9.13 | 5.24 | -13.53 | -2.18 | Upgrade
|
| Free Cash Flow Margin | -20.11% | -16.26% | 6.62% | -18.37% | -3.45% | Upgrade
|
| Free Cash Flow Per Share | -0.51 | -0.45 | 0.29 | -0.77 | -0.21 | Upgrade
|
| Cash Interest Paid | 3.24 | 2.01 | 1.13 | 0.99 | - | Upgrade
|
| Cash Income Tax Paid | 0.05 | 0.13 | 0.18 | 0.17 | 0.16 | Upgrade
|
| Levered Free Cash Flow | -8.35 | -18.48 | -4.79 | -24.51 | -4.25 | Upgrade
|
| Unlevered Free Cash Flow | -6.51 | -17.1 | -4.09 | -23.31 | -2.43 | Upgrade
|
| Change in Working Capital | -11.9 | -3.77 | -1.66 | 6.19 | 14.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.